{"title": "Home | GSK", "author": null, "url": "https://www.gsk.com/en-gb/home/", "hostname": "gsk.com", "description": "At GSK, we unite science, technology and talent to get ahead of disease together", "sitename": "Gsk", "date": "2023-09-08", "cleaned_text": "European Respiratory Society (ERS) International Congress 2023 Together, we are redefining respiratory care Over four days, we'll be hosting eight symposia and sharing more than forty abstracts, conveying our commitment, expertise and ongoing innovation in the field of respiratory disease Our strategy We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive. Our R&D focus is on four therapeutic areas: infectious diseases, HIV, respiratory/immunology and oncology Behind the science Discover how we're getting ahead [ ](/en-gb/behind-the-science-magazine/amr-antibiotics-resistance-superbugs-new-medicines/) 'It's insidious and it's getting worse': AMR and the urgent need for novel antibiotics [ ](/en-gb/behind-the-science-magazine/maps-technology-new-age-vaccine-development-infectious-diseases/) 'The roar I hear is the next stage of the rocket firing': MAPS technology and the new age of vaccine development [ ](/en-gb/behind-the-science-magazine/hepatitis-b-patient-quote-story-functional-cure/) '300 million people with chronic hepatitis B are waiting to re-start their lives. This is my story of hope.' [ ](/en-gb/behind-the-science-magazine/fresh-insights-could-finally-help-us-tackle-rsv/) Fresh insights could finally help us tackle RSV [ ](/en-gb/behind-the-science-magazine/men-women-gender-diversity-clinical-trials/) 'We're not a world of men - it's as simple as that': how gender diversity in clinical trials improves health outcomes for women [ ](/en-gb/behind-the-science-magazine/shingles-symptoms-risks-pain-adults/) 'I had never experienced anything like it': the pain, risks, and first symptoms of shingles every adult should know [ ](/en-gb/behind-the-science-magazine/age-related-decline-immunity-infectious-disease/) Age-related decline in immunity: why does it matter and what can be done about it? [ ](/en-gb/behind-the-science-magazine/ai-and-ml-power-better-predictions-for-patient-impact/) AI and ML power better predictions for patient impact Life at GSK How we help people thrive Culture Growth Diversity, equity and inclusion Wellbeing Outstanding people [ INNOVATING TOGETHER 2022 Meet Euan: using technology in drug discovery ](/en-gb/company/outstanding-people/innovating-together-2022/#meet-euan:-using-technology-in-drug-discovery) [ INNOVATING TOGETHER 2022 Meet Mugdha: working together to help more patients ](/en-gb/company/outstanding-people/innovating-together-2022/#meet-mugdha:-working-together-to-help-more-patients) [ INNOVATING TOGETHER 2022 Meet Pal: combining the power of genetics and genomics ](/en-gb/company/outstanding-people/innovating-together-2022/#meet-pal:-combining-the-power-of-genetics-and-genomics) [ WORKING TOGETHER Meet P.J.: how a life-changing diagnosis changed his career ](/en-gb/company/outstanding-people/working-together/#meet-p.j.:-how-a-life-changing-diagnosis-changed-his-career) [ WORKING TOGETHER Meet Jess: advocating for patients ](/en-gb/company/outstanding-people/working-together/#meet-jess:-advocating-for-patients) [ WORKING TOGETHER Meet Fiona: improving health and wellbeing through nature ](/en-gb/company/outstanding-people/working-together/#-meet-fiona:-improving-health-and-wellbeing-through-nature) Positively impacting society and the planet Access We are making our products affordable and available to more people around the world through responsible pricing, strategic access programmes and partnerships. Global health and health security We are committed to using our science, our partnerships, and the knowledge we've gained from addressing the world's biggest health challenges to improve health globally. Environment We're committed to work towards a net zero, nature positive, healthier planet, with ambitious goals set for 2030 and 2045. Diversity, equity and inclusion Our work supports the health of all kinds of people. To meet our diverse patients' needs better, we need diversity in our clinical trials and to support our own people to thrive as part of an inclusive team. Ethical standards Our culture guides our people to do the right thing and act on any concerns they have. Product governance Ensuring the quality, safety and reliable supply of our products is critical to our purpose of uniting science, talent and technology to get ahead of disease together. "}